The PubChem BioAssay involves a FRET-based biochemical high throughput dose response assay to identify inhibitors of ADAM10 as a counterscreen for exosite inhibitors of ADAM17. It is classified as a confirmatory assay and falls under the category of Binding assays. Does this molecule show effectiveness in this assay?